Reliant Healthcare, Care Fusion Rx merge as part of new PE-backed platform Combined company will be led by Frank Alderman, co-founder and former CEO of MedExpress

By HME News Staff
Updated 9:39 AM CST, Mon November 24, 2025
CHICAGO – Reliant Healthcare has been recapitalized by Shore Capital Partners and merged with Care Fusion Rx. The combined company will unite Reliant’s established presence across the South with Care Fusion’s leadership in advanced immunoglobulin treatments throughout the West Coast.
Together, the two companies will be well-positioned to drive national care through new center openings, home infusion territory expansion, and strategic acquisitions in both high-growth and underserved infusion markets, says Shore Capital Partners.
“We are thrilled to partner with Reliant and Care Fusion to build a differentiated infusion platform focused on quality, access and growth,” said Mike Cooper, founding partner at Shore Capital Partners, a Chicago-based private equity firm with $14 billion of assets under management.
Frank Alderman, M.D., co-founder and former CEO of MedExpress, will serve as lead independent director for the platform.
About Reliant: Founded in 2008, the provider of home infusion therapy and ambulatory infusion center services operates 14 centers and multiple specialty pharmacies across Louisiana, Texas and Oklahoma.
“This partnership represents a tremendous opportunity to enhance how and where patients receive infusion therapy,” said Brad Smith, CEO of Reliant Healthcare. “By combining two organizations with deep clinical expertise and shared values, we are creating a platform capable of delivering even more consistent, accessible, affordable, and compassionate care to patients who rely on these therapies every day.”
About Care Fusion: Founded in 2020, the California-based infusion therapy company serves thousands of patients at the local level and across complex conditions such as neurology, immunology, oncology, rare disease, rheumatology and gastroenterology.
“Joining forces with Reliant allows us to extend that commitment to more patients, leverage our combined operational strengths, and continue improving outcomes for individuals living with chronic and rare conditions,” said Steve Roberts, co-founder of Care Fusion Rx.
Houlihan Lokey and Guggenheim Securities, LLC served as financial advisors and DLA Piper, McDermott Will & Schulte, and Quarles & Brady served as legal advisors to Shore Capital. Brentwood Capital served as financial advisor and Bass, Berry & Sims PLC served as legal advisor to Reliant. Covington Associates served as financial advisor and Polsinelli served as legal advisor to Care Fusion.
Comments